with the advance of biochemistry, digital/structure, and wide arrays of CRO steps from screening to pre-clinical efficacy becomes straight forward. The bottle neck seems to be the first step: target selection. Too few disease-drivers which attract huge crowd!
![[TALK 21] AlphaFold: Use and Applications - Sami Chaaban](http://i.ytimg.com/vi/yJKfn6rvHmg/mqdefault.jpg)
![[TALK 21] AlphaFold: Use and Applications – Sami Chaaban](/img/tr.png)
![[TALK 18] Using Proteome Discoverer to Interrogate your Data - Cat Franco](http://i.ytimg.com/vi/tID8GK6QUWw/mqdefault.jpg)
with the advance of biochemistry, digital/structure, and wide arrays of CRO steps from screening to pre-clinical efficacy becomes straight forward. The bottle neck seems to be the first step: target selection. Too few disease-drivers which attract huge crowd!